Rapid resolution of leptomeningeal disease with targeted therapy in a metastatic melanoma patient

J Neurooncol. 2017 Jul;133(3):663-665. doi: 10.1007/s11060-017-2472-2. Epub 2017 May 20.

Authors

Isabella C Glitza¹, Sherise D Ferguson², Nandita Guha-Thakurta³

Affiliations

¹ Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. icglitza@mdanderson.org.
² Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
³ Department of Diagnostic Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

PMID: 28528423
DOI: 10.1007/s11060-017-2472-2

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Drug Therapy, Combination
Enzyme Inhibitors / therapeutic use
Humans
Ipilimumab / therapeutic use
Lateral Ventricles / diagnostic imaging
Magnetic Resonance Imaging
Male
Melanoma / pathology*
Meningeal Neoplasms / diagnostic imaging
Meningeal Neoplasms / secondary*
Meningeal Neoplasms / therapy*

Substances

Enzyme Inhibitors
Ipilimumab